Tower Research Capital LLC (TRC) - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$4,000
+300.0%
447
+73.9%
0.00%
Q1 2016$1,000
-80.0%
257
-73.3%
0.00%
-100.0%
Q4 2015$5,000
+25.0%
963
+37.6%
0.00%
Q3 2015$4,000
-96.8%
700
-91.2%
0.00%
-100.0%
Q2 2015$126,000
-57.9%
7,953
-71.1%
0.01%
-70.3%
Q1 2015$299,000
+7375.0%
27,478
+6874.1%
0.04%
Q4 2014$4,000394
+7780.0%
0.00%
Q1 2014$0
-100.0%
5
-99.7%
0.00%
-100.0%
Q4 2013$23,000
-32.4%
1,758
-22.5%
0.00%0.0%
Q3 2013$34,0002,2680.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2015
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders